In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-19 of 19 for your search:
Drug:  dactinomycin
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NICHD
Protocol IDs: PPRU 10762, NCT00491946
2.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 50
Sponsor: NCI, Other
Protocol IDs: CDR0000068608, EURO-EWING-INTERGROUP-EE99, EBMT-INTERGROUP-EE99, EORTC-62981, GPOH-AUSTRIA-INTERGROUP-EE99, GPOH-GERMANY-INTERGROUP-EE99, SFOP-INTERGROUP-EE99, SWS-SAKK-INTERGROUP-EE99, CCLG-INTERGROUP-EE99, COG-AEWS0331, EU-20213, AEWS0331, NCT00020566
3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000257531, SIOP-WT-2001, SFOP-SIOP-WT-2001, CCLG-SIOP-WT-2001, GPOH-GERMANY-SIOP-WT-2001, EU-20208, NCT00047138
4.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 30 at diagnosis
Sponsor: NCI
Protocol IDs: COG-AREN0532, AREN0532, NCT00352534
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 50
Sponsor: NCI
Protocol IDs: COG-ARST0531, NCT00354835, ARST0531
6.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AREN0533, AREN0533, NCT00379340
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 21
Sponsor: Other
Protocol IDs: CCLG-EPSSG-RMS-2005, EU-20639, EUDRACT-2005-000217-35, UKCCSG-RMS-2005, NCT00379457
8.

Phase: Phase III
Type: Treatment
Status: Active
Age: Under 30 at initial diagnosis
Sponsor: NCI
Protocol IDs: COG-AREN0534, AREN0534, NCT00945009
9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 4 to 50
Sponsor: Other
Protocol IDs: 108128, EudraCT number: 2008-003658-13, NCT00987636
10.

Phase: Phase III
Type: Tissue collection/Repository, Treatment
Status: Active
Age: No age specified
Sponsor: Other
Protocol IDs: CPT-SIOP-2009, NCT01014767
11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: GOG-0275, GOG-0275, NCT01535053
12.

Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 20 and under
Sponsor: Other
Protocol IDs: 0413, NCT01661335
13.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-X335, NCT01531244
14.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: JRSG-UHA-PED03-02, NCT00245089
15.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 18
Sponsor: Other
Protocol IDs: JRSG-UHA-PED03-01, NCT00245141
16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AREN0321, AREN0321, NCT00335556
17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10-101, NCT01323517
18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 50
Sponsor: NCI
Protocol IDs: COG-ARST08P1, ARST08P1, NCT01055314
19.

Phase: No phase specified
Type: Tissue collection/Repository, Treatment
Status: Active
Age: Under 21
Sponsor: Other
Protocol IDs: PPB Reg Tx-Biol-001, NCT01464606
New Search